Related Experiment Video
Updated: Jan 20, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
A case of malignant melanoma after repeated recurrent dysplastic nevi
Dae Kyun Jeong1, Yong Chan Bae1,2, So Jeong Lee3
1Department of Plastic and Reconstructive Surgery, Pusan National University School of Medicine, Busan, Korea.
Abstract:
Dysplastic nevus is common and affects about 10% of the northern European-descendent population. Studies over the past several decades have identified dysplastic nevi as a risk factor for malignant melanoma. Furthermore, in rare cases, they confirmed that dysplastic nevi have progressed to melanoma. Cases in which dysplastic nevi progressed to malignant melanoma in multiple studies are not uncommon. A 35-year-old woman presented with the major symptom of multiple itchy brown nodules (2.0 cm× 1.3 cm) in the left cheek that had first appeared 20 years earlier. Complete excision was performed at the first visit; subsequent biopsy confirmed that they were dysplastic nevi. They recurred three times over 3 years at the same site, all of which were histologically diagnosed as dysplastic nevi. Five years after the final excision, a brownish nodule developed in the left cheek, with others at the left temporal region, right retroauricular region, and left shoulder at the same time. These lesions were histologically diagnosed as malignant melanoma. We experienced a case of malignant melanoma that occurred at the same site after three recurrences of dysplastic nevi. Although rare, the possibility of malignant melanoma should be considered in follow-ups in cases involving repeatedly recurrent dysplastic nevi.
Related Concept Videos
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
08:32Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
09:52Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
03:52Experimental Metastatic Melanoma Mouse Model: A Platform to Study the Metastatic Potential of Melanoma Cells in the Lungs
07:07A Melanoma Patient-Derived Xenograft Model
10:23Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

